Glucagon, which should be suppressed in the presence of hyperinsulinemia, is also elevated in insulin-resistant individuals with obesity [325], contributing to the fasting and postprandial hyperglycemia in these individuals. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.